基于网络药理学分析和动物实验探讨益气活血通络方治疗膝骨关节炎的作用机制OA
Investigation of the mechanism of Yiqi Huoxue Tongluo Fang(益气活血通络方)in the treatment of knee osteo-arthritis based on the network pharmacology analysis and animal experiments
目的:探讨益气活血通络方治疗膝骨关节炎(knee osteoarthritis,KOA)的作用机制.方法:①网络药理学分析.采用超高效液相色谱-静电场轨道阱高分辨质谱法鉴定益气活血通络方的化学成分,进一步采用网络药理学方法筛选益气活血通络方治疗 KOA 的核心成分和关键靶点,同时对筛选出的关键靶点基因进行 GO 功能和 KEGG 通路富集分析,并对关键靶点和核心成分进行分子对接验证.②动物实验.将48 只 SPF 级雌性 SD 大鼠随机分为6 组,每组8 只.除空白组外,模型组、塞来昔布组及益气活血通络方低、中、高剂量组大鼠均采用前交叉韧带离断法在左后肢进行 KOA 造模.造模术后第4 周开始进行药物干预,益气活血通络方低、中、高剂量组分别以0.65 g·mL-1、1.30 g·mL-1、2.60 g·mL-1 益气活血通络方(配方颗粒)双蒸水溶液灌胃,塞来昔布组以2.065 mg·mL-1塞来昔布双蒸水溶液灌胃,空白组和模型组给予等体积双蒸水灌胃,每日1 次,每次2 mL,连续4 周.药物干预结束后,取左后肢膝关节进行 Micro-CT 检查、组织病理学观察(HE 染色、番红 O-固绿染色、甲苯胺蓝染色),并采用免疫荧光技术和 Western Blot 技术检测软骨组织中 Y 染色体性别决定区-盒转录因子9(sex determining region Y-box transcription factor 9,SOX9)和肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)蛋白表达水平.结果:①网络药理学分析结果.筛选出的益气活血通络方治疗 KOA 的核心成分包括 α-亚麻酸、柚皮素、甘草素、芹菜素及木犀草素,关键靶点包括 SRC、信号转导及转录活化因子 3(signal transducer and activator of transcription 3,STAT3)、Akt 激酶(Akt kinase,Akt)1、磷脂酰肌醇3-激酶调节亚基1(phosphatidyl-inositol-3-kinase regulatory subunit 1,PI3KR1)、磷脂酰肌醇 3-激酶催化亚基 α(phosphatidylinositol-3-kinase catalytic subunit alpha,PI3KCA).GO 富集分析显示筛选出的关键靶点主要参与信号传导、炎症反应及细胞增殖正向调节等生物学过程;KEGG 通路富集分析提示其可能通过调控低氧诱导因子 1(hypoxia-inducible factor 1,HIF-1)、磷脂酰肌醇 3-激酶(phosphatidylinositol-3-kinase,PI3K)-Akt、TNF-α、丝裂原激活的蛋白激酶(mitogen-activated protein kinase,MAPK)等信号通路发挥治疗作用.分子对接结果显示,核心成分中芹菜素、甘草素、柚皮素与筛选出的关键靶点结合较好.②动物实验结果.Micro-CT 检查结果显示,模型组软骨下骨出现明显骨丢失(骨小梁体积分数、骨小梁数量、骨小梁厚度降低,骨小梁分离度升高);益气活血通络方高剂量组的上述骨微结构指标明显改善,且效果优于塞来昔布组;益气活血通络方各剂量组的改善效果呈现剂量依赖性趋势.组织病理学观察显示,模型组软骨表面严重剥脱、裂隙形成,蛋白聚糖显著丢失,基质异染性减弱;益气活血通络方各剂量组的上述病理损害均有所改善,效果呈剂量依赖性趋势,高剂量组效果最佳,且与塞来昔布组相当.免疫荧光和 Western Blot 检测结果显示,模型组 SOX9 蛋白表达水平降低、TNF-α 蛋白表达水平升高;与模型组相比,益气活血通络方高剂量组 SOX9 蛋白表达水平升高、TNF-α 表达水平降低,效果与塞来昔布组相当.结论:益气活血通络方治疗 KOA 的核心药效成分为芹菜素、甘草素、柚皮素,作用靶点为 SRC、STAT3、Akt1、PI3KR1 及 PI3KCA;其作用机制可能是通过调控 HIF-1、PI3K-Akt、TNF-α 及 MAPK 等信号通路,抑制炎症反应、促进软骨修复及改善软骨下骨微结构.
Objective:To investigate the mechanism of Yiqi Huoxue Tongluo Fang(益气活血通络方,YHTF)in the treatment of knee oste-oarthritis(KOA).Methods:①Network pharmacology analysis.The chemical ingredients of YHTF were identified using ultra-high perfor-mance liquid chromatography-Orbitrap mass spectrometry(UHPLC-Orbitrap-MS).Furthermore,the network pharmacology approach was em-ployed to screen the core ingredients and key targets of YHTF against KOA.GO function and KEGG pathway enrichment analyses were then performed on the identified key target genes,and the molecular docking validation was conducted between key targets and core ingredients.②Animal experiment.Forty-eight SPF-grade female SD rats were randomized into blank group,model group,celecoxib group,low-dose YHTF(L-YHTF)group,medium-dose YHTF(M-YHTF)group,high-dose YHTF(H-YHTF)group,with 8 ones in each group.All rats but the ones in the blank group were subjected to anterior cruciate ligament transection(ACLT)on the left hind limbs to build KOA model.At 4 weeks post-modeling procedure,the rats in L-YHTF group,M-YHTF group,and H-YHTF group were intervened by intragastric administra-tion with YHTF solution(formula granules dissolved in double-distilled water)at concentrations of 0.65,1.30,and 2.60 g/mL,respective-ly,the ones in celecoxib group with celecoxib solution(celecoxib dissolved in double-distilled water)at a concentration of 2.065 mg/mL,while the ones in the blank group and model group with an equal volume of double-distilled water.All rats in the 6 groups were intervened once a day,2 mL at a time for consecutive 4 weeks.Following the end of intervention,the left hind knee joints were harvested from the rats in each group for Micro-CT examination and histopathological observation(HE staining,safranin O-fast green(SO-FG)staining,and tolui-dine blues taining).Additionally,the protein expression levels of sex determining region Y-box transcription factor 9(SOX9)and tumor nec-rosis factor-α(TNF-α)were detected using immunofluorescence and Western Blot.Results:①Findings from network pharmacology analy-sis.The core ingredients of YHTF against KOA were identified as α-linolenic acid,naringenin,liquiritigenin,apigenin,and luteolin.The key targets included SRC,signal transducer and activator of transcription 3(STAT3),Akt kinase(Akt)1,phosphatidylinositol-3-kinase regulato-ry subunit 1(PI3KR1),and phosphatidylinositol-3-kinase catalytic subunit alpha(PI3KCA).GO function enrichment analysis revealed that the screened key targets were mainly involved in biological processes such as signal transduction,inflammatory response,and positive regu-lation of cell proliferation.KEGG signaling pathway enrichment analysis revealed that YHTF may exert its anti-KOA effects through regu-lating hypoxia-inducible factor 1(HIF-1),phosphatidylinositol-3-kinase(PI3K)-Akt,TNF-α,and mitogen-activated protein kinase(MAPK)signaling pathways.Molecular docking results showed that the apigenin,liquiritigenin,and naringenin among the core ingredients exhibited good binding affinity with the screened key targets.②Findings from animal experiment.Micro-CT revealed significant subchondral bone loss in the model group(decreased trabecular bone volume/tissue volume(Tb.BV/TV),trabecular number(Tb.N),and trabecular thickness(Tb.Th),and increased trabecular separation(Tb.Sp)).The aforementioned bone microstructural indices were significantly improved in the H-YHTF group,with efficacy superior to the celecoxib group.The improvements in the L-,M-and H-YHTF groups showed a dose-dependent trend.Histopathological examination showed severe cartilage surface erosion,fissure formation,marked proteoglycan loss,and re-duced matrix metachromasia in the model group.The aforementioned pathological damages were improved in all YHTF groups,showing a dose-dependent trend,with the H-YHTF group achieving the best effect,which was comparable to that of the celecoxib group.Immunofluo-rescence and Western blot results showed that the protein expression level of SOX9 was downregulated,while that of TNF-α was upregulated in the model group.whereas,compared with the model group,the protein expression level of SOX9 was upregulated,while that of TNF-α was downregulated in H-YHTF group,with effects comparable to those of the celecoxib group.Conclusion:The core active ingredients of YHTF against KOA are apigenin,liquiritigenin,and naringenin,acting on the targets of SRC,STAT3,Akt1,PI3KR1,and PI3KCA.It may exert the effects by regulating HIF-1,PI3K-Akt,TNF-α,and MAPK signaling pathways,thereby inhibiting inflammatory responses,promoting cartilage repair,and improving subchondral bone microstructure.
韩明丽;何敏聪;杨帆;吴淮;魏秋实;何宪顺;韩龙飞;罗贵锋;田龙;林锟;陆舜;侯文渊;李美霞
广州中医药大学,广东 广州 510405广州中医药大学,广东 广州 510405广州中医药大学,广东 广州 510405深圳平乐骨伤科医院/深圳市坪山区中医院,广东 深圳 518118深圳平乐骨伤科医院/深圳市坪山区中医院,广东 深圳 518118广州中医药大学,广东 广州 510405广州中医药大学,广东 广州 510405广州中医药大学,广东 广州 510405广州中医药大学,广东 广州 510405广州中医药大学,广东 广州 510405广州中医药大学,广东 广州 510405广州中医药大学,广东 广州 510405广州中医药大学,广东 广州 510405
骨关节炎,膝益气活血通络方网络药理学分子对接模拟液相色谱-质谱法动物实验
osteoarthritis,kneeYiqi Huoxue Tongluo Fangnetwork pharmacologymolecular docking simulationliquid chromatography-mass spectrometryanimal experimentation
《中医正骨》 2026 (5)
9-23,15
2025年度深圳市基础研究专项自然科学基金计划项目(JCY120250604190412017)
评论